The pharmaceutical industry is on the brink of a radical transformation, driven by the integration of advanced technologies such as artificial intelligence (AI) and quantum computing. Sanofi, an undisputed leader in the sector, continues to demonstrate the importance of AI in drug research and development (R&D). Concurrently, innovations like AWS GraphRAG and advancements by Insilico Medicine illustrate AI's potential to reduce development cycles and improve treatment efficacy. However, these advances come with significant regulatory and ethical challenges, necessitating a rapid adaptation of existing frameworks.
Débloquez l'Analyse Complète
Accédez instantanément à nos insights exclusifs générés par IA, basés sur l'agrégation de centaines de sources sectorielles.
